Overview
- 27 inspections across 23 sites are on record.
- 160 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-01-13.
At a glance
Inspections
27
Sites
23
Observations
160
Career since
Apr 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PPL Healthcare LLC | 13 Jan 2023 | Human Drugs | On file |
| ZebraSci, Inc. | 18 Nov 2022 | Human Drugs | |
| QualTech Laboratories, Inc. | 25 Oct 2022 | Human Drugs | |
| A.P. Deauville, LLC | 25 Aug 2022 | Human Drugs | View 483 → |
| Mylan Pharmaceuticals Inc | 26 May 2022 | Human Drugs | View 483 → |
Sites inspected
PPL Healthcare LLCSellersville, United States1 insp.
ZebraSci, Inc.Branchburg, United States1 insp.
QualTech Laboratories, Inc.Ocean, United States1 insp.
A.P. Deauville, LLCEaston, United States1 insp.
Mylan Pharmaceuticals IncMorgantown, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Janet A Rajan4 shared
Anastasia M Shields4 shared
Gayle S Lawson3 shared
James M Mason3 shared
Ankur C Patel2 shared
Guerlain Ulysse2 shared
Tamil Arasu2 shared
Atul Agrawal2 shared
Marcus A Ray2 shared
Junho Pak1 shared
Full investigator report
Get the verbatim findings behind Ko U Min's 160 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site